Dr. Francesco De Santis
Italfarmaco Holding S.p.A.
Via dei Lavoratori, 54
20092 Cinisello Balsamo (MI)
Tel.: 02/6443.2110
Fax:  02/644340

Career Since 2013 President of Italfarmaco Spa (25/06/2013)

Since 1995 President of Italfarmaco Holding  S.p.A. (12/06/1995) and President of part of the Group subsidiaries.

1992-2007 President of Tecnofarmaci - Associated Company for Pharmaceutical Research.

2001-2008 President of C4T- Colosseum Combinatorial Chemistry Centre for Technology S.c.a r.l.

1987-1995  President of Italfarmaco Spa.

1985-1986  Managing Director of Italfarmaco Spa.
Social commitments 2020-2024 Vice President of Confindustria with responsibility for Research and Development.

2020-2022 Member of the Farmindustria Committee.

2013-2020 Vice President of Farmindustria. Charge previously covered for the biennium 2011-2015 and 1999-2001.

2003-2022 Vice President of the Control Committee of the Code of Ethics of Farmindustria.

2017-2019 Farmindustria representative in the Confindustria General Council.

2017 Member of Confindustria Research & Development Technical Group.

2012-2014 Member of the Technical Research and Innovation Committee of Confindustria.

2004-2008 Member of the Advisory Board of the Master in Pharmaceutical Marketing (University of Pavia).

2002-2003 Chairman of the Control Committee of the Code of Ethics of Farmindustria.

From 1994 to 2002 Member of the Control Committee of the Code of Ethics of Farmindustria.

1999 Research Delegate for Farmindustria and Relations with the CRUI.

1989-2005 Member of the SISF Executive Board - Company Italiana Scienze Farmaceutiche.

Since 1987 Member of the Board Farmindustria.

1984-1985 Member The New York Academy of Science.

In the Italfarmaco Group Francesco De Santis enters in Italfarmaco in 1981 at the age of 25 and has been covering during his career the different positions of Managing Directo, Director of the Board, President of Italfarmaco Spa and is President of Italfarmaco Holding. He has personally driven the foundation and internationalization process of all of the Group’s companies.